Jason Meyenburg: CEO of Gemini Therapeutics
BioBoss13 Jun 2020

Jason Meyenburg: CEO of Gemini Therapeutics

Gemini Therapeutics CEO Jason Meyenburg share his thoughts about leadership in biopharma with BioBoss host John Simboli. Jason also discusses Gemini Therapeutics pioneering approach to developing precision medicines by leveraging genetics to work in diseases like dry AMD and linked diseases that have limited or no solutions.

Denne episoden er hentet fra en åpen RSS-feed og er ikke publisert av Podme. Den kan derfor inneholde annonser.

Episoder(96)

Hyung Heon Kim: CEO of MetaVia

Hyung Heon Kim: CEO of MetaVia

Hyung Heon Kim, CEO of MetaVia, shares his insights about leadership in biopharma and how MetaVia is working to transform cardiometabolic disease.

6 Mai 32min

David Southwell: CEO of Volastra Therapeutics

David Southwell: CEO of Volastra Therapeutics

David Southwell, CEO of Volastra Therapeutics, shares his insights about leadership in biopharma and how Volastra is working to discover and develop oncology therapeutics targeting chromosomal instabi...

28 Feb 31min

Stacy Lindborg: CEO of Imunon

Stacy Lindborg: CEO of Imunon

Stacy Lindborg, CEO of Imunon, shares her insights about leadership in biopharma and how Imunon is working to develop medicines that harness the building blocks of life to work in harmony with the bod...

26 Jan 33min

Welcome to Season 8 of BioBoss

Welcome to Season 8 of BioBoss

BioBoss podcast host John Simboli reflects on Seasons 1-6 and invites listeners to Season 7 starting in January 2026

20 Des 20251min

Michael Cloonan: CEO of Sionna Therapeutics

Michael Cloonan: CEO of Sionna Therapeutics

Michael Cloonan, CEO of Sionna Therapeutics, shares his insights about leadership in biopharma and how Sionna is working to restore the cystic fibrosis transmembrane conductance regulator for people l...

22 Nov 202544min

Erik van den Berg: CEO of Memo Therapeutics

Erik van den Berg: CEO of Memo Therapeutics

Erik van den Berg, CEO of Memo Therapeutics, shares his insights about leadership in biopharma and how Memo is working to develop antibodies to transform the lives of patients with viral infections an...

27 Okt 202530min

Bruce Leuchter: CEO of Neurvati Neurosciences

Bruce Leuchter: CEO of Neurvati Neurosciences

Bruce Leuchter, CEO of Neurvati Neurosciences, shares his insights about leadership in biopharma and how Neurvati is working to advance drugs with the potential to improve the health and lives of peop...

29 Sep 202546min

Todd Harris: CEO of Tyra Biosciences

Todd Harris: CEO of Tyra Biosciences

Todd Harris, CEO of Tyra Biosciences, shares his insights about leadership in biopharma and how Tyra is working to develop precision medicines that target large fibroblast growth factor receptor biolo...

30 Aug 202529min

Populært innen Business og økonomi

stopp-verden
lydartikler-fra-aftenposten
dine-penger-pengeradet
rss-penger-polser-og-politikk
e24-podden
rss-borsmorgen-okonominyhetene
rss-skravla-gar
pengepodden-2
rss-pa-konto
livet-pa-veien-med-jan-erik-larssen
finansredaksjonen
pengesnakk
utbytte
morgenkaffen-med-finansavisen
rss-sunn-okonomi
stormkast-med-valebrokk-stordalen
lederpodden
tid-er-penger-en-podcast-med-peter-warren
okonomiamatorene
rss-fa-makro